FDA Flagged GLP-1 Vision Loss Signal in 2025, but U.S. Ozempic and Mounjaro Labels Still Lack NAION Warning
Publisher
Global
This page provides publisher metadata, and related coverage to support discovery before sending readers to the attributed publisher through Google News.
Open via Google NewsAt a glance
- Publisher
- inkl
- Region
- Global
- Scope
- discovery
- Published
- September 29, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
This record currently routes through Google News. Confirm important claims against the publisher or a primary record.
Source: inkl
Scope: discovery
Evidence: Tier 3 · Aggregated media
Related coverage
More related coverage
Weekly all-cause mortality surveillance: week ending 11 April 2027 (week 16)
How the actual number of deaths in England compare with expected numbers for each week.
Weekly all-cause mortality surveillance: week ending 4 April 2027 (week 15)
How the actual number of deaths in England compare with expected numbers for each week.
Adult social care client level data, England: quarterly update
Official statistics in development on insights from client level data from local authorities, includ...
Adult social care client level data, England: quarterly update to March 2026
Official statistics in development on insights from client level data from local authorities, includ...